LIFEMD INC (LFMD) Stock Fundamental Analysis
NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to LFMD. LFMD was compared to 36 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMD have multiple concerns. LFMD is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year LFMD has reported negative net income.
In the past year LFMD had a positive cash flow from operations.
LFMD had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMD reported negative operating cash flow in multiple years.
1.2 Ratios
LFMD has a Return On Assets (-18.79%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD's Gross Margin of 87.99% is amongst the best of the industry. LFMD outperforms 94.44% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
Compared to 5 years ago, LFMD has more shares outstanding
Compared to 1 year ago, LFMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.97 indicates that LFMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
LFMD's Altman-Z score of 1.97 is fine compared to the rest of the industry. LFMD outperforms 63.89% of its industry peers.
LFMD has a debt to FCF ratio of 5.81. This is a neutral value as LFMD would need 5.81 years to pay back of all of its debts.
LFMD has a better Debt to FCF ratio (5.81) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 1.97 |
ROIC/WACCN/A
WACC10.79%
2.3 Liquidity
A Current Ratio of 0.82 indicates that LFMD may have some problems paying its short term obligations.
The Current ratio of LFMD (0.82) is worse than 80.56% of its industry peers.
LFMD has a Quick Ratio of 0.82. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LFMD (0.77) is worse than 80.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.05% over the past year.
The Revenue has grown by 43.07% in the past year. This is a very strong growth!
The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
3.2 Future
Based on estimates for the next years, LFMD will show a very strong growth in Earnings Per Share. The EPS will grow by 41.78% on average per year.
LFMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.03% yearly.
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
LFMD is valuated quite expensively with a Price/Forward Earnings ratio of 32.07.
Based on the Price/Forward Earnings ratio, LFMD is valued a bit cheaper than the industry average as 69.44% of the companies are valued more expensively.
LFMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 32.07 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LFMD is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as LFMD.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 151.27 | ||
| EV/EBITDA | 177.01 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFMD's earnings are expected to grow with 41.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.53%
EPS Next 3Y41.78%
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.55
-0.55 (-4.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.39%
Inst Owner Change0.4%
Ins Owners17.86%
Ins Owner Change4.94%
Market Cap479.50M
Analysts81.33
Price Target14.28 (35.36%)
Short Float %10.78%
Short Ratio2.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-22.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.21%
Min EPS beat(2)61.87%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)28.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-4.25%
EPS beat(12)5
Avg EPS beat(12)-13.27%
EPS beat(16)6
Avg EPS beat(16)-14.35%
Revenue beat(2)2
Avg Revenue beat(2)6.37%
Min Revenue beat(2)2.97%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)2.84%
Revenue beat(12)7
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)14.29%
PT rev (3m)16.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.52%
EPS NY rev (1m)0%
EPS NY rev (3m)132.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 32.07 | ||
| P/S | 2.05 | ||
| P/FCF | 151.27 | ||
| P/OCF | 31.18 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 177.01 |
EPS(TTM)-0.34
EYN/A
EPS(NY)0.33
Fwd EY3.12%
FCF(TTM)0.07
FCFY0.66%
OCF(TTM)0.34
OCFY3.21%
SpS5.15
BVpS-0.05
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% | ||
| FCFM | 1.35% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2.6 | ||
| Cap/Depr | 121.5% | ||
| Cap/Sales | 5.22% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 587.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 1.97 |
F-Score5
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
EBIT growth 1Y58.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.77%
EBIT Next 3Y72.64%
EBIT Next 5YN/A
FCF growth 1Y112.29%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y188.08%
OCF growth 3YN/A
OCF growth 5Y133.93%